PO.CL05.09 · 临床研究

肥胖塑造了一种可逆的免疫微环境,促进乳腺癌生长

Obesity shapes a reversible immune microenvironment that fosters breast cancer growth

海报缩略图:肥胖塑造了一种可逆的免疫微环境,促进乳腺癌生长
编号 6572 展板 5 时间 4/21 02:00–05:00 区域 Section 45 主讲 Tao Zhang, PhD
分会场 Inflammation, Immunity, and Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Tao Zhang1, Shimeng Liu1, Yi Zhang2, Alva Yijia Jiang1, Zachary Sandusky1, Na Zhang1, Tara Akhshi1, Nicole Traphagen1, Jack Yueyang Wang1, Lucas Tian1, Esme Wheeler1, Yingtian Xie1, Rong Li1, Buraq Ahmed1, Genevra Kuziel1, Capucine Heraud1, Mohammed Mutaher1, Henry Long1, Kornelia Polyak1, Myles A. Brown1

1Dana-Farber Cancer Institute, Boston, MA,2Duke University, Durham, NC

摘要 Abstract

中文摘要
肥胖与乳腺癌风险和严重程度相关,但其潜在机制仍不清楚。利用单细胞RNA测序,我们在小鼠肥胖和乳腺癌模型的乳腺肿瘤和脂肪组织中鉴定出C1q+巨噬细胞的作用。巨噬细胞来源的C1q促进对肥胖相关凋亡脂肪细胞的清除,增强脂质代谢,并通过产生前列腺素E2(PGE2)导致免疫抑制性肿瘤微环境。此外,肿瘤相关巨噬细胞(TAM)通过诱导募集单核细胞的细胞因子的产生,与肿瘤细胞形成前馈环路,进一步抑制抗肿瘤免疫反应。阻断C1q、TNF-alpha和PGE2合成可减少肥胖小鼠的肿瘤生长。重要的是,通过饮食改变或胰高血糖素样肽-1受体(GLP-1R)激动实现的体重减轻降低了C1q表达并抑制了肥胖驱动的肿瘤生长。干预免疫抑制环境和前馈环路可能是改善肥胖乳腺癌患者预后的可行策略。
查看英文原文 English abstract
Obesity is linked to breast cancer risk and severity, yet the underlying mechanisms remain unclear. Using single-cell RNA sequencing, we identified a role for C1q+ macrophages in mammary tumors and adipose tissues in mouse obesity and breast cancer models. Macrophage-derived C1q promotes the clearance of obesity-associated apoptotic adipocytes, enhancing lipid metabolism and leading to an immunosuppressive tumor microenvironment via the production of prostaglandin E2 (PGE2). Moreover, the tumor-associated macrophages (TAMs) engage tumor cells in a feedforward loop by inducing the production of monocyte-recruiting cytokines further suppressing the anti-tumor immune response. Blockade of C1q, TNF-alpha, and PGE2 synthesis reduced tumor growth in obese mice. Importantly, weight loss via dietary changes or glucagon-like peptide-1 receptor (GLP-1R) agonism decreased C1q expression and suppressed obesity-driven tumor growth. Interference with the immunosuppressive environment and the feedforward loop may be viable strategies for improving the outcomes of breast cancer patients with obesity.
利益披露 Disclosure
T. Zhang, None.. S. Liu, None.. A. Jiang, None.. N. Zhang, None.. J. Wang, None.. L. Tian, None.. E. Wheeler, None.. Y. Xie, None.. R. Li, None.. B. Ahmed, None.. G. Kuziel, None.. C. Heraud, None.. M. Mutaher, None.. H. Long, None.. K. Polyak, None.

← 返回 AACR 2026 检索